Global Antimicrobial Resistance Diagnostics Market
Medical Equipment

How Will The Antimicrobial Resistance Diagnostics Market Reach $5.82 Billion By 2029 Amid Global Shifts?

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Antimicrobial Resistance Diagnostics Market?

The market size for antimicrobial resistance diagnostics has seen substantial growth in the past few years. The market is projected to expand from $4.10 billion in 2024 to $4.41 billion in 2025, registering a compound annual growth rate (CAGR) of 7.5%. Factors that have contributed to this growth in the past include a rise in hospital-acquired infections, inappropriate use of antibiotics in humans and animals, the growing prevalence of multidrug-resistant organisms, an increase in public health monitoring programs, and a surge in diagnostic testing for infectious diseases.

In the coming years, the antimicrobial resistance diagnostics market is projected to experience robust growth. Estimated to rise to $5.82 billion by 2029 with a compound annual growth rate (CAGR) of 7.2%, the growth during this forecast period can be linked to the increasing demand for swift diagnostic devices, heightened awareness on antimicrobial stewardship, escalating government support for resistance tracking, and the growing utilization of point-of-care testing. Noteworthy trends expected during this period encompass technological progression in diagnostic platforms, innovative techniques in resistance gene discovery, increased investment in research and development, creation of transportable testing equipment, and pioneering developments in multiplex and high-throughput testing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25696&type=smp

What Growth-Enabling Forces Are Impacting The Antimicrobial Resistance Diagnostics Market?

The growth of the antimicrobial resistance diagnostics market is anticipated to be fueled by the increasing occurrence of drug-resistant infections. Such infections, resistant to previously effective medications, evolve when bacteria, viruses, fungi, or parasites develop survival mechanisms making standard treatments useless and infections more challenging to control. The expansion of drug-resistant infections can be attributed to the excessive use of antibiotics in farming—low-dose antimicrobials are routinely included in animal feed, fostering resistance that can spread to humans via the food chain. Essential tools for battling the escalating occurrence of drug-resistant infections, antimicrobial resistance diagnostics like rapid genetic assays and culture-based sensitivity tests, help with the early detection of resistant pathogens, guide targeted therapies, and lower the misuse of broad-spectrum antibiotics. As an example, a UK Health Security Agency (UKHSA) report in November 2023 stated that antibiotic-resistant infections in England increased from 55,792 cases in 2021 to around 58,224 in 2022, indicative of a 4% annual increase in antimicrobial resistance across the country. Hence, the escalating occurrence of drug-resistant infections is fueling the growth of the antimicrobial resistance diagnostics market.

How Does The Antimicrobial Resistance Diagnostics Market Differ By Segment?

The antimicrobial resistance diagnostics market covered in this report is segmented –

1) By Product Type: Kits And Reagents, Instruments And Consumables

2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens

3) By Technology: Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies

4) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Polymerase Chain Reaction (PCR) Reagents, Immunoassay Reagents, Stains And Dyes, Culture Media

2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines, Ultraviolet-Visible (UV-Vis) Spectrophotometers, Next-Generation Sequencing (NGS) Systems, Microarray Scanners, Automated Liquid Handlers, Sample Collection Tubes And Swabs

What New Opportunities Are Emerging From Trends In The Antimicrobial Resistance Diagnostics Market?

Leading corporations in the antimicrobial resistance diagnostics market are zeroing in on the production of innovative products like multiplex polymerase chain reaction (PCR) assays. These can detect multiple pathogens and resistance genes concurrently, improving both the efficacy and accuracy of diagnosis. Multiplex PCR consolidates several primer sets in one reaction to recognize various DNA targets simultaneously, which saves time and resources considerably. For example, Vela Diagnostics, a molecular diagnostics firm from Singapore, introduced the PathoKey MP urinary tract infections (UTI) ID and antimicrobial resistance (AMR) PCR Test in May 2022. This product allows for the concurrent detection of 14 UTI pathogens and 14 antimicrobial resistance genes. Plus, it supports both automated and manual workflows and can deliver results in just four hours, aiding quick, lab-scale AMR profiling. The PathoKey MP UTI ID & AMR PCR Test is aimed at equipping clinical laboratories with speedy, high-throughput detection abilities, facilitating early intervention and effective antibiotic treatment.

Who Are The Most Influential Companies In The Antimicrobial Resistance Diagnostics Market?

Major companies operating in the antimicrobial resistance diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Seegene Inc., Alifax S.r.l., Accelerate Diagnostics Inc., Lumos Diagnostics Holdings Pty Ltd, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc., OpGen Inc., T2 Biosystems, Jiangsu Medomics Medical Technology Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/antimicrobial-resistance-diagnostics-global-market-report

Which Region Is Leading Innovation In The Antimicrobial Resistance Diagnostics Market?

North America was the largest region in the antimicrobial resistance diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25696&type=smp

Browse Through More Reports Similar to the Global Antimicrobial Resistance Diagnostics Market 2025, By The Business Research Company

Breast Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Metastatic Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metastatic-cancer-drugs-global-market-report

Skin Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model